PPAR Research / 2013 / Article / Fig 1

Clinical Study

Dual PPAR α/γ Agonism Normalizes Lipoprotein Profile of Renal Dyslipidemia

Figure 1

Plasma lipid concentrations at baseline and after six-week treatment with 1 mg tesaglitazar o.d. (mean and standard error of the mean).
391628.fig.001a
(a)
391628.fig.001b
(b)
391628.fig.001c
(c)
391628.fig.001d
(d)